France

Dashboard Indicators

  • Long-term Control of Eczema Symptoms

    Scores are based on responses to the AD Control Tool: https://www.adcontroltool.com/adct-how-to-use/adct-in-clinical-practice

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Satisfaction with Eczema Treatments

    Self reported satisfaction with current treatments (caregivers and adults).

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Life Span Trade-Off (Health Utility)

    Percent of remaining life span adult patients would trade off in order to be restored to perfect health. (Derived from EQ5D Utility Scores).

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Eczema Patients Self Reported Health to Compared to Country Average

    Self-rated quality of life score for the average person compared to the self-rated quality of life score for adults with eczema.

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Dimensions of Health – Relative Impact (Adults)

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Financial Burden – Impacts

    Percent of respondents (adults and caregivers) who reported using savings, borrowing money and/or reducing spending due to eczema. Higher = More Financial Impact

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Shared Decision Making

    The percentage of respondents who indicated that the healthcare provider whom they see for eczema asked about their priorities for their eczema care at the most recent visit.

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Eczema Education and Training

    Respondents who said a health care provider had ever suggested they attend an eczema training program that happens after the office visit.

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Access to Dermatologists

    France ranks 5th out of the 10 countries studied on this measure.

    “Source: Demographics of Healthcare Professionals - Doctors by Place of Registration .” Directorate of Research, Studies, Evaluation, and Statistics , Ministére des Solidarités et de la Santé, 1 Jan. 2021, drees.shinyapps.io/demographie-ps/.

  • Evidence-Based Guidelines

    French guidelines for eczema care met some criteria but are more than 5 years old, did not involve patients in the development process, and do not cover all patient ages.

    Scoring criteria for the guideline measure >

    Source: SFDermatologie. “Site Professionnel De La Société Française De Dermatologie Et De Pathologie Sexuellement Transmissible.” Pour La Pratique - Recommandations - Société Française De Dermatologie - Atopic Dermatitis , 2005, www.sfdermato.org/media/pdf/recommandation/da-long-21929906693b437d6f4315bef48d1518.pdf.

Literature Review Key Findings

 

The French literature is notable for its nuanced analysis of the impacts of AD on the sexual health of both patients and their partners. The French literature also includes studies of adolescents and their parents, which have been understudied in the other countries of interest. There are also several studies which detail the mental health burden experienced by patients in France. 

One study of sleep difficulty, anxiety, and depression in a French cohort of patients found that 57.4% of patients reported anxiety, and 73.0% of patients reported depression as measured by the PHQ-9 scale. Of the patients whose score indicated depression, 37.5% had moderate depression, and 7.0% severe depression. This study provides some context for healthcare utilization by patients with AD in France, but there is likely more research needed in this area.

The French literature contains several studies on topical steroid concerns among both patients and healthcare providers. One study describes the success of a therapeutic patient education program at alleviating such concerns supporting the notion that educational interventions may be an effective method for increasing adherence and generating downstream improvements in disease severity and QoL. 

Learn more about the findings gathered from the France literature review.